Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion
about
Strategies for treatment in Alexander diseaseMolecular dissection of reactive astrogliosis and glial scar formationNogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasmStathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systemsProteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage.A Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood PlasmaExperimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice.Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum.IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disabilityAstrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis.Upregulation of vascular endothelial growth factor receptor-3 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitisInterleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelinationEctonucleotidase activity and immunosuppression in astrocyte-CD4 T cell bidirectional signaling.Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons.Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis.Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.Recent molecular approaches to understanding astrocyte function in vivo.Reactivated astrocytes as a possible source of oligodendrocyte precursors for remyelination in remitting phase of experimental autoimmune encephalomyelitis rats.Astrocyte barriers to neurotoxic inflammation.Role of GFAP in CNS injuries.Aquaporin-4 deficiency attenuates acute lesions but aggravates delayed lesions and microgliosis after cryoinjury to mouse brain.Aggravated inflammation and increased expression of cysteinyl leukotriene receptors in the brain after focal cerebral ischemia in AQP4-deficient miceSalutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitisTargeting the thrombin receptor modulates inflammation and astrogliosis to improve recovery after spinal cord injurySuppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels.Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease.Palm Fruit Bioactives modulate human astrocyte activity in vitro altering the cytokine secretome reducing levels of TNFα, RANTES and IP-10
P2860
Q24596794-7F4968D2-BBF8-47C4-9059-18C7304EE140Q24646628-DE85CF04-8F15-4DC1-9F2F-F252774F3230Q27313149-6138A808-4610-4BFC-987B-0B7223D2AD5AQ28586380-AA407F53-2D88-469C-9D41-B1C08B95E6AAQ33513478-4D973194-5086-4DBF-AAEC-7CB890B0A8A4Q33799866-E36C98D4-4828-4890-AC51-2ADABC30CA7EQ34192220-3293CE39-8E5F-421F-A037-FA3C7A06B881Q34259303-F01A1149-7DCB-4C6F-ACDC-610BBE396CD1Q34359503-0295158C-F4F7-413A-8B03-CD15E8842521Q35129497-E8F2C8AB-7169-4D38-BF38-ABF49F2B531EQ35242814-6BF4EF6C-5465-4AE0-96CF-18A0BC7155F9Q36326348-34ED3EEF-2E50-4282-BAF2-4E186E7C401CQ36500155-DDE1B4F7-681B-4271-85B3-4C2A2092012BQ36584434-9D156146-9E6C-44C1-AEEC-AA38055F14F6Q36905624-2808D8D6-32E5-4723-B32D-851AAB5E9289Q36955863-EFDE31AC-66C5-4A36-956D-860EDAA2F692Q37163112-DD6CCC7A-E1C9-4B59-B58B-3BAED6C1095CQ37401147-13BB2BD5-C4ED-4957-963F-E46FA21A2EBCQ37403700-2058A6AE-7821-45F5-912C-DB5DACD46C39Q37412106-370CFEED-18E6-4846-B544-D4D880078F29Q37553848-57BE989B-5249-4DF7-8CFF-BEC6C6CF4707Q37597818-C81AC450-C67E-4843-92CE-67716B9ED4A3Q38186427-77D7B970-9E93-4943-AB48-EC62386D64A9Q41441907-3C1A0930-B132-4CF3-BEE1-511400DBB15DQ41452642-27A83C7D-F563-4A2A-AB6B-3012C07339A7Q41594953-DD5D6302-72CC-4C09-BDF6-ACADAD7560A7Q41922463-3F6F57B9-B610-4D99-8348-917B17217D32Q47117550-3C839E87-782C-43C4-85BB-3C1DD9FD04DBQ47308800-9A9FECA7-67FA-4943-8840-B5E5B9FB30F9Q58608796-FE19E385-1592-4733-813C-31FA62E4D2DC
P2860
Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Experimental autoimmune enceph ...... central nervous system lesion
@ast
Experimental autoimmune enceph ...... central nervous system lesion
@en
type
label
Experimental autoimmune enceph ...... central nervous system lesion
@ast
Experimental autoimmune enceph ...... central nervous system lesion
@en
prefLabel
Experimental autoimmune enceph ...... central nervous system lesion
@ast
Experimental autoimmune enceph ...... central nervous system lesion
@en
P2093
P2860
P1476
Experimental autoimmune enceph ...... central nervous system lesion
@en
P2093
R Kucherlapati
W Edelmann
P2860
P304
P407
P577
1998-01-01T00:00:00Z